These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 15634025

  • 1. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H3 receptor antagonists.
    Zaragoza F, Stephensen H, Peschke B, Rimvall K.
    J Med Chem; 2005 Jan 13; 48(1):306-11. PubMed ID: 15634025
    [Abstract] [Full Text] [Related]

  • 2. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
    Zaragoza F, Stephensen H, Knudsen SM, Pridal L, Wulff BS, Rimvall K.
    J Med Chem; 2004 May 20; 47(11):2833-8. PubMed ID: 15139761
    [Abstract] [Full Text] [Related]

  • 3. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD, Sher R, Berlin M, Shih NY, Aslanian R, Schwerdt JH, McCormick KD, Piwinski JJ, West RE, Anthes JC, Williams SM, Wu RL, She HS, Rivelli MA, Mutter JC, Corboz MR, Hey JA, Favreau L.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):395-9. PubMed ID: 16246552
    [Abstract] [Full Text] [Related]

  • 4. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M, Ting PC, Vaccaro WD, Aslanian R, McCormick KD, Lee JF, Albanese MM, Mutahi MW, Piwinski JJ, Shih NY, Duguma L, Solomon DM, Zhou W, Sher R, Favreau L, Bryant M, Korfmacher WA, Nardo C, West RE, Anthes JC, Williams SM, Wu RL, Susan She H, Rivelli MA, Corboz MR, Hey JA.
    Bioorg Med Chem Lett; 2006 Feb 15; 16(4):989-94. PubMed ID: 16297617
    [Abstract] [Full Text] [Related]

  • 5. Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.
    Stark H, Hüls A, Ligneau X, Arrang JM, Schwartz JC, Schunack W.
    Pharmazie; 1997 Jul 15; 52(7):495-500. PubMed ID: 9266588
    [Abstract] [Full Text] [Related]

  • 6. omega-(Imidazol-4-yl)alkane-1-sulfonamides: a new series of potent histamine H(3) receptor antagonists.
    Tozer MJ, Buck IM, Cooke T, Kalindjian SB, Pether MJ, Steel KI.
    Bioorg Med Chem; 2002 Feb 15; 10(2):425-32. PubMed ID: 11741790
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and structure-activity relationships of acetylene-based histamine H3 receptor antagonists.
    Ali SM, Tedford CE, Gregory R, Handley MK, Yates SL, Hirth WW, Phillips JG.
    J Med Chem; 1999 Mar 11; 42(5):903-9. PubMed ID: 10072687
    [Abstract] [Full Text] [Related]

  • 8. 4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.
    Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W.
    J Med Chem; 1998 Oct 08; 41(21):4171-6. PubMed ID: 9767653
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.
    J Pharmacol Exp Ther; 1999 May 08; 289(2):1151-9. PubMed ID: 10215699
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.
    Morini G, Comini M, Rivara M, Rivara S, Bordi F, Plazzi PV, Flammini L, Saccani F, Bertoni S, Ballabeni V, Barocelli E, Mor M.
    Bioorg Med Chem; 2008 Dec 01; 16(23):9911-24. PubMed ID: 18976927
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.
    Ganellin CR, Fkyerat A, Bang-Andersen B, Athmani S, Tertiuk W, Garbarg M, Ligneau X, Schwartz JC.
    J Med Chem; 1996 Sep 13; 39(19):3806-13. PubMed ID: 8809168
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel imidazole-based histamine H3 antagonists.
    Jablonowski JA, Ly KS, Bogenstaetter M, Dvorak CA, Boggs JD, Dvorak LK, Lord B, Miller KL, Mazur C, Wilson SJ, Lovenberg TW, Carruthers NI.
    Bioorg Med Chem Lett; 2009 Feb 01; 19(3):903-7. PubMed ID: 19119007
    [Abstract] [Full Text] [Related]

  • 20. 4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.
    Dvorak CA, Apodaca R, Barbier AJ, Berridge CW, Wilson SJ, Boggs JD, Xiao W, Lovenberg TW, Carruthers NI.
    J Med Chem; 2005 Mar 24; 48(6):2229-38. PubMed ID: 15771465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.